Ultragenyx Pharmaceutical Inc. (RARE)
Novato, CA
Total Compensation for Fiscal Year Ending in 2024: $13,717,687
| Salary | $856,008 |
|---|---|
| Bonus | $0 |
| Value of Stock Awards | $9,374,511 |
| Value of Option Awards | $2,715,600 |
| Non-Equity Incentive Plan Compensation | $757,768 |
| Change in Pension Value and Deferred Compensation Earnings | $0 |
| All Other Compensation | $13,800 |
| Total | $13,717,687 |
Ultragenyx Pharmaceutical Inc. disclosed its CEO pay was
42
times its median employee's pay for the fiscal year ending in 2024.
How Do You Compare?
